Enfusion

Enfusion EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Enfusion (ENFN) as of Nov 7, 2026 is 4.30 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 10.96 % — a change of -60.82% (lower).

EBIT/Assets

4.30 %

YoY

-60.82%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Enfusion is 2024 4.30 % . Operating Income to Assets Ratio (EBIT/Assets) of Enfusion was 2023 10.96 % . It decreases by -60.82% lower compared to the previous year.

The Enfusion EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
59.79 USD
Jan 1, 2020
15.53 USD
Jan 1, 2021
-261.18 USD
Jan 1, 2022
-9.67 USD
Jan 1, 2023
10.96 USD
Jan 1, 2024
4.30 USD
The Enfusion EBIT/Assets history
YEAREBIT/AssetsYoY
4.30 %-60.82%
10.96 %-213.44%
-9.67 %-96.30%
-261.18 %-1,781.22%
15.53 %-74.02%
59.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Operating Income to Assets Ratio (EBIT/Assets) of Enfusion is 4.30 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Enfusion changed from 10.96 % to 4.30 %, representing a -60.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Enfusion since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Enfusion

All Key Metrics — Enfusion